These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 15200425)
1. Differential effects of simvastatin on mesangial cells. Heusinger-Ribeiro J; Fischer B; Goppelt-Struebe M Kidney Int; 2004 Jul; 66(1):187-95. PubMed ID: 15200425 [TBL] [Abstract][Full Text] [Related]
2. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins). Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529 [TBL] [Abstract][Full Text] [Related]
3. Regulation of connective tissue growth factor (ccn2; ctgf) gene expression in human mesangial cells: modulation by HMG CoA reductase inhibitors (statins). Goppelt-Struebe M; Hahn A; Iwanciw D; Rehm M; Banas B Mol Pathol; 2001 Jun; 54(3):176-9. PubMed ID: 11376131 [TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: Implications for diabetic nephropathy. Danesh FR; Sadeghi MM; Amro N; Philips C; Zeng L; Lin S; Sahai A; Kanwar YS Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8301-5. PubMed ID: 12048257 [TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor [CTGF]/CCN2 stimulates mesangial cell migration through integrated dissolution of focal adhesion complexes and activation of cell polarization. Crean JK; Furlong F; Finlay D; Mitchell D; Murphy M; Conway B; Brady HR; Godson C; Martin F FASEB J; 2004 Oct; 18(13):1541-3. PubMed ID: 15319369 [TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of statins on fetal bovine serum-induced proliferation of rat cultured mesangial cells and correlation between their inhibitory effect and transport characteristics. Nagasawa K; Muraki Y; Matsuda T; Ohnishi N; Yokoyama T J Pharm Sci; 2000 Dec; 89(12):1594-604. PubMed ID: 11042608 [TBL] [Abstract][Full Text] [Related]
7. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Blanco-Colio LM; Villa A; Ortego M; Hernández-Presa MA; Pascual A; Plaza JJ; Egido J Atherosclerosis; 2002 Mar; 161(1):17-26. PubMed ID: 11882313 [TBL] [Abstract][Full Text] [Related]
8. Effect of simvastatin on proliferative nephritis and cell-cycle protein expression. Yoshimura A; Nemoto T; Sugenoya Y; Inui K; Watanabe S; Inoue Y; Sharif S; Yokota N; Uda S; Morita H; Ideura T Kidney Int Suppl; 1999 Jul; 71():S84-7. PubMed ID: 10412745 [TBL] [Abstract][Full Text] [Related]
9. Simvastatin potentiates tumor necrosis factor alpha-mediated apoptosis of human vascular endothelial cells via the inhibition of the geranylgeranylation of RhoA. Tang D; Park HJ; Georgescu SP; Sebti SM; Hamilton AD; Galper JB Life Sci; 2006 Sep; 79(15):1484-92. PubMed ID: 16740276 [TBL] [Abstract][Full Text] [Related]
10. Effects of fungal statins on high-glucose-induced mouse mesangial cell hypocontractility may involve filamentous actin, t-complex polypeptide 1 subunit beta, and glucose regulated protein 78. Hwang JC; Chang LC; Lin YF; Shui HA; Chen JS Transl Res; 2010 Aug; 156(2):80-90. PubMed ID: 20627192 [TBL] [Abstract][Full Text] [Related]
12. HMG-CoA reductase inhibitors decrease angiotensin II-induced vascular fibrosis: role of RhoA/ROCK and MAPK pathways. Rupérez M; Rodrigues-Díez R; Blanco-Colio LM; Sánchez-López E; Rodríguez-Vita J; Esteban V; Carvajal G; Plaza JJ; Egido J; Ruiz-Ortega M Hypertension; 2007 Aug; 50(2):377-83. PubMed ID: 17592071 [TBL] [Abstract][Full Text] [Related]
13. Direct inhibitory effects of simvastatin on matrix accumulation in cultured murine mesangial cells. Nogaki F; Muso E; Yashiro M; Kasuno K; Kamata T; Ono T; Sasayama S Kidney Int Suppl; 1999 Jul; 71():S198-201. PubMed ID: 10412775 [TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Park HJ; Kong D; Iruela-Arispe L; Begley U; Tang D; Galper JB Circ Res; 2002 Jul; 91(2):143-50. PubMed ID: 12142347 [TBL] [Abstract][Full Text] [Related]
15. Modulation of the expression of connective tissue growth factor by alterations of the cytoskeleton. Ott C; Iwanciw D; Graness A; Giehl K; Goppelt-Struebe M J Biol Chem; 2003 Nov; 278(45):44305-11. PubMed ID: 12951326 [TBL] [Abstract][Full Text] [Related]
16. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin. Takeda N; Kondo M; Ito S; Ito Y; Shimokata K; Kume H Am J Respir Cell Mol Biol; 2006 Dec; 35(6):722-9. PubMed ID: 16858009 [TBL] [Abstract][Full Text] [Related]
17. The role of geranylgeranylated proteins in human mesangial cell proliferation. Khwaja A; Sharpe CC; Noor M; Hendry BM Kidney Int; 2006 Oct; 70(7):1296-304. PubMed ID: 16929252 [TBL] [Abstract][Full Text] [Related]
18. RhoA signaling modulates cyclin D1 expression in human lung fibroblasts; implications for idiopathic pulmonary fibrosis. Watts KL; Cottrell E; Hoban PR; Spiteri MA Respir Res; 2006 Jun; 7(1):88. PubMed ID: 16776827 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of RhoA signaling prevents connective tissue growth factor induction in endothelial cells exposed to non-uniform shear stress. Cicha I; Goppelt-Struebe M; Muehlich S; Yilmaz A; Raaz D; Daniel WG; Garlichs CD Atherosclerosis; 2008 Jan; 196(1):136-145. PubMed ID: 17452038 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin suppresses self-renewal of mouse embryonic stem cells by inhibiting RhoA geranylgeranylation. Lee MH; Cho YS; Han YM Stem Cells; 2007 Jul; 25(7):1654-63. PubMed ID: 17464088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]